| 发明名称 |
PHARMACEUTICAL COMPOSITIONS |
| 摘要 |
A pharmaceutical solution for a medication delivery apparatus, especially a metered dose inhaler, is described. The pharmaceutical solution comprises: (a) a liquefied propellant component consisting essentially of and preferably consisting entirely of 1,1-difluoroethane (R-152a); (b) ethanol; and (c) a drug component dissolved in the propellant/ethanol mixture consisting of at least one drug selected from the group consisting of beclomethasone dipropionate (BDP) and fluticasone propionate (FP). |
| 申请公布号 |
US2014234229(A1) |
申请公布日期 |
2014.08.21 |
| 申请号 |
US201214117340 |
申请日期 |
2012.05.11 |
| 申请人 |
Corr Stuart;Noakes Timothy James |
发明人 |
Corr Stuart;Noakes Timothy James |
| 分类号 |
A61K31/573;A61K31/56;A61K9/00 |
主分类号 |
A61K31/573 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical solution for delivery using a medication delivery apparatus to treat a respiratory disorder comprising:
(a) a liquefied propellant component consisting essentially of or consisting entirely of 1,1-difluoroethane (R-152a); (b) 1.0 to 20.0 weight % of ethanol based on the total weight of the pharmaceutical solution; and (c) a drug component dissolved in the propellant/ethanol mixture consisting of at least one drug selected from the group consisting of beclomethasone dipropionate (BDP) and fluticasone propionate (FP). |
| 地址 |
Cheshire GB |
